Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
May 2022	61	Global Markets Direct	ASDR-601529

Published: May 2022 - Pages : 61 - Publisher : Global Markets Direct - Report code : ASDR-601529

Anavex Life Sciences Corp
Apnimed Inc
Dermavant Sciences Inc
Karuna Therapeutics Inc
Sinsin Pharmaceutical Co Ltd
TheraVida Inc
Trigone Pharma Ltd